130 related articles for article (PubMed ID: 27807695)
1. Pharmacological Tool Compounds for the Free Fatty Acid Receptor 4 (FFA4/GPR120).
Hansen SV; Ulven T
Handb Exp Pharmacol; 2017; 236():33-56. PubMed ID: 27807695
[TBL] [Abstract][Full Text] [Related]
2. The pharmacology of TUG-891, a potent and selective agonist of the free fatty acid receptor 4 (FFA4/GPR120), demonstrates both potential opportunity and possible challenges to therapeutic agonism.
Hudson BD; Shimpukade B; Mackenzie AE; Butcher AJ; Pediani JD; Christiansen E; Heathcote H; Tobin AB; Ulven T; Milligan G
Mol Pharmacol; 2013 Nov; 84(5):710-25. PubMed ID: 23979972
[TBL] [Abstract][Full Text] [Related]
3. Targeting FFA1 and FFA4 receptors in cancer-induced cachexia.
Freitas RDS; Muradás TC; Dagnino APA; Rost FL; Costa KM; Venturin GT; Greggio S; da Costa JC; Campos MM
Am J Physiol Endocrinol Metab; 2020 Nov; 319(5):E877-E892. PubMed ID: 32893672
[TBL] [Abstract][Full Text] [Related]
4. Probe-Dependent Negative Allosteric Modulators of the Long-Chain Free Fatty Acid Receptor FFA4.
Watterson KR; Hansen SVF; Hudson BD; Alvarez-Curto E; Raihan SZ; Azevedo CMG; Martin G; Dunlop J; Yarwood SJ; Ulven T; Milligan G
Mol Pharmacol; 2017 Jun; 91(6):630-641. PubMed ID: 28385906
[TBL] [Abstract][Full Text] [Related]
5. Improving metabolic stability with deuterium: The discovery of GPU-028, a potent free fatty acid receptor 4 agonists.
Li Z; Xu X; Li G; Fu X; Liu Y; Feng Y; Wang M; Ouyang Y; Han J
Bioorg Med Chem; 2017 Dec; 25(24):6647-6652. PubMed ID: 29100735
[TBL] [Abstract][Full Text] [Related]
6. Functions of omega-3 fatty acids and FFA4 (GPR120) in macrophages.
Im DS
Eur J Pharmacol; 2016 Aug; 785():36-43. PubMed ID: 25987421
[TBL] [Abstract][Full Text] [Related]
7. FFA4 (GPR120) as a fatty acid sensor involved in appetite control, insulin sensitivity and inflammation regulation.
Im DS
Mol Aspects Med; 2018 Dec; 64():92-108. PubMed ID: 28887275
[TBL] [Abstract][Full Text] [Related]
8. Treatment with TUG891, a free fatty acid receptor 4 agonist, restores adipose tissue metabolic dysfunction following chronic sleep fragmentation in mice.
Gozal D; Qiao Z; Almendros I; Zheng J; Khalyfa A; Shimpukade B; Ulven T
Int J Obes (Lond); 2016 Jul; 40(7):1143-9. PubMed ID: 26980479
[TBL] [Abstract][Full Text] [Related]
9. Activity of dietary fatty acids on FFA1 and FFA4 and characterisation of pinolenic acid as a dual FFA1/FFA4 agonist with potential effect against metabolic diseases.
Christiansen E; Watterson KR; Stocker CJ; Sokol E; Jenkins L; Simon K; Grundmann M; Petersen RK; Wargent ET; Hudson BD; Kostenis E; Ejsing CS; Cawthorne MA; Milligan G; Ulven T
Br J Nutr; 2015 Jun; 113(11):1677-88. PubMed ID: 25916176
[TBL] [Abstract][Full Text] [Related]
10. Dietary Fatty Acids and Their Potential for Controlling Metabolic Diseases Through Activation of FFA4/GPR120.
Ulven T; Christiansen E
Annu Rev Nutr; 2015; 35():239-63. PubMed ID: 26185978
[TBL] [Abstract][Full Text] [Related]
11. Exploration of phenylpropanoic acids as agonists of the free fatty acid receptor 4 (FFA4): Identification of an orally efficacious FFA4 agonist.
Sparks SM; Aquino C; Banker P; Collins JL; Cowan D; Diaz C; Dock ST; Hertzog DL; Liang X; Swiger ED; Yuen J; Chen G; Jayawickreme C; Moncol D; Nystrom C; Rash V; Rimele T; Roller S; Ross S
Bioorg Med Chem Lett; 2017 Mar; 27(5):1278-1283. PubMed ID: 28148462
[TBL] [Abstract][Full Text] [Related]
12. Agonism of free fatty acid receptors 1 and 4 generates peptide YY-mediated inhibitory responses in mouse colon.
Moodaley R; Smith DM; Tough IR; Schindler M; Cox HM
Br J Pharmacol; 2017 Dec; 174(23):4508-4522. PubMed ID: 28971469
[TBL] [Abstract][Full Text] [Related]
13. Free-fatty acid receptor-4 (GPR120): Cellular and molecular function and its role in metabolic disorders.
Moniri NH
Biochem Pharmacol; 2016 Jun; 110-111():1-15. PubMed ID: 26827942
[TBL] [Abstract][Full Text] [Related]
14. Characterizing pharmacological ligands to study the long-chain fatty acid receptors GPR40/FFA1 and GPR120/FFA4.
Milligan G; Alvarez-Curto E; Watterson KR; Ulven T; Hudson BD
Br J Pharmacol; 2015 Jul; 172(13):3254-65. PubMed ID: 25131623
[TBL] [Abstract][Full Text] [Related]
15. GPR120: Mechanism of action, role and potential for medical applications.
Karakuła-Juchnowicz H; Róg J; Juchnowicz D; Morylowska-Topolska J
Postepy Hig Med Dosw (Online); 2017 Nov; 71(0):942-953. PubMed ID: 29176006
[TBL] [Abstract][Full Text] [Related]
16. The role of free-fatty acid receptor-4 (FFA4) in human cancers and cancer cell lines.
Senatorov IS; Moniri NH
Biochem Pharmacol; 2018 Apr; 150():170-180. PubMed ID: 29452095
[TBL] [Abstract][Full Text] [Related]
17. Functional analysis of free fatty acid receptor GPR120 in human eosinophils: implications in metabolic homeostasis.
Konno Y; Ueki S; Takeda M; Kobayashi Y; Tamaki M; Moritoki Y; Oyamada H; Itoga M; Kayaba H; Omokawa A; Hirokawa M
PLoS One; 2015; 10(3):e0120386. PubMed ID: 25790291
[TBL] [Abstract][Full Text] [Related]
18. Oral administration of the selective GPR120/FFA4 agonist compound A is not effective in alleviating tissue inflammation in mouse models of prototypical autoimmune diseases.
Wannick M; Bezdek S; Guillen N; Thieme M; Meshrkey F; Mousavi S; Seeling M; Nimmerjahn F; Mócsai A; Zillikens D; Sezin T; Sadik CD
Pharmacol Res Perspect; 2018 Dec; 6(6):e00438. PubMed ID: 30455959
[TBL] [Abstract][Full Text] [Related]
19. Docosahexaenoic acid and TUG-891 activate free fatty acid-4 receptor in bovine neutrophils.
Olmo I; Teuber S; Larrazabal C; Alarcon P; Raipane F; Burgos RA; Hidalgo MA
Vet Immunol Immunopathol; 2019 Mar; 209():53-60. PubMed ID: 30885306
[TBL] [Abstract][Full Text] [Related]
20. Involvement of FFA1 and FFA4 in the regulation of cellular functions during tumor progression in colon cancer cells.
Takahashi K; Fukushima K; Onishi Y; Minami K; Otagaki S; Ishimoto K; Fukushima N; Honoki K; Tsujiuchi T
Exp Cell Res; 2018 Aug; 369(1):54-60. PubMed ID: 29750897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
